| P2093 | author name string | D Scott Merrell | |
| | Dennis P McDaniel | |
| | Hanan Gancz | |
| | Beth M Carpenter | |
| | Morris O Makobongo | |
| P2860 | cites work | A novel mechanism of programmed cell death in bacteria by toxin-antitoxin systems corrupts peptidoglycan synthesis | Q21145777 |
| | New concepts of resistance in the treatment of Helicobacter pylori infections | Q24622513 |
| | LL-37, the neutrophil granule- and epithelial cell-derived cathelicidin, utilizes formyl peptide receptor-like 1 (FPRL1) as a receptor to chemoattract human peripheral blood neutrophils, monocytes, and T cells | Q24675869 |
| | Structural and DNA-binding studies on the bovine antimicrobial peptide, indolicidin: evidence for multiple conformations involved in binding to membranes and DNA | Q24814019 |
| | Structure and mechanism of action of an indolicidin peptide derivative with improved activity against gram-positive bacteria | Q27631108 |
| | Antimicrobial peptides of multicellular organisms | Q28131811 |
| | A common mechanism of cellular death induced by bactericidal antibiotics | Q28246128 |
| | Comparison of the membrane association of two antimicrobial peptides, magainin 2 and indolicidin | Q28362033 |
| | Oxazolidinones: a review | Q28373208 |
| | A single nucleotide change affects fur-dependent regulation of sodB in H. pylori | Q29346540 |
| | Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria? | Q29547675 |
| | A PhoP-regulated outer membrane protease of Salmonella enterica serovar typhimurium promotes resistance to alpha-helical antimicrobial peptides. | Q30453404 |
| | Gene expression profiling of Helicobacter pylori reveals a growth-phase-dependent switch in virulence gene expression. | Q30477751 |
| | Rostrocaudal analysis of corpus callosum demyelination and axon damage across disease stages refines diffusion tensor imaging correlations with pathological features | Q30495412 |
| | The oxazolidinones as a new family of antimicrobial agent | Q30664774 |
| | Structure-activity relationships of antibacterial acyl-lysine oligomers | Q33329010 |
| | Epidemiological link between gastric disease and polymorphisms in VacA and CagA. | Q33627481 |
| | Helicobacter pylori virulence and genetic geography | Q33639332 |
| | Experimental infection of Mongolian gerbils with wild-type and mutant Helicobacter pylori strains. | Q33765863 |
| | Diversity of antimicrobial peptides and their mechanisms of action | Q33789705 |
| | Mechanism of the binding, insertion and destabilization of phospholipid bilayer membranes by alpha-helical antimicrobial and cell non-selective membrane-lytic peptides | Q33789716 |
| | A miniature mimic of host defense peptides with systemic antibacterial efficacy | Q33868731 |
| | Activation of beta-catenin by carcinogenic Helicobacter pylori | Q33906825 |
| | Activation of TLR2 by a small molecule produced by Staphylococcus epidermidis increases antimicrobial defense against bacterial skin infections | Q34069196 |
| | Mechanisms of antimicrobial peptide action and resistance | Q34181099 |
| | Global analysis of Helicobacter pylori gene expression in human gastric mucosa | Q34338182 |
| | Generation of Helicobacter pylori ghosts by PhiX protein E-mediated inactivation and their evaluation as vaccine candidates | Q34531903 |
| | American College of Gastroenterology guideline on the management of Helicobacter pylori infection | Q34645482 |
| | Who's Winning the War? Molecular Mechanisms of Antibiotic Resistance in Helicobacter pylori | Q35104855 |
| | The relationship between peptide structure and antibacterial activity | Q35690395 |
| | Staphylococcus aureus resistance to human defensins and evasion of neutrophil killing via the novel virulence factor MprF is based on modification of membrane lipids with l-lysine | Q36369306 |
| | Low eradication rate of Helicobacter pylori with triple 7-14 days and quadriple therapy in Turkey | Q36474120 |
| | Peptide antimicrobial agents | Q36538861 |
| | Damage of the outer membrane of enteric gram-negative bacteria by lactoferrin and transferrin | Q37000367 |
| | Structure-activity analysis of buforin II, a histone H2A-derived antimicrobial peptide: the proline hinge is responsible for the cell-penetrating ability of buforin II. | Q37219123 |
| | Quadruple therapy with furazolidone for retreatment in patients with peptic ulcer disease | Q37386612 |
| | In vitro antibacterial activity of acyl-lysyl oligomers against Helicobacter pylori | Q37392936 |
| | Degradation of human antimicrobial peptide LL-37 by Staphylococcus aureus-derived proteinases | Q37624709 |
| | Activation of the complement system generates antibacterial peptides | Q37695583 |
| | Iron and pH homeostasis intersect at the level of Fur regulation in the gastric pathogen Helicobacter pylori | Q38317457 |
| | Design of novel indolicidin-derived antimicrobial peptides with enhanced cell specificity and potent anti-inflammatory activity | Q38354256 |
| | Serum immunoglobulin G immune response to Helicobacter pylori antigens in Mongolian gerbils | Q39464027 |
| | Penicillin-binding proteins of gram-negative bacteria | Q39537937 |
| | Microtubules Are required for motility and positioning of vesicles and mitochondria in hyphal tip cells of Allomyces macrogynus | Q39562435 |
| | Compounds which increase the permeability of the Pseudomonas aeruginosa outer membrane | Q39848915 |
| | Use of the fluorescent probe 1-N-phenylnaphthylamine to study the interactions of aminoglycoside antibiotics with the outer membrane of Pseudomonas aeruginosa | Q39849104 |
| | alpha-Defensin inhibits influenza virus replication by cell-mediated mechanism(s). | Q40092958 |
| | Molecular architecture and functioning of the outer membrane of Escherichia coli and other gram-negative bacteria | Q40144766 |
| | Antiplasmodial activity of lauryl-lysine oligomers | Q40169806 |
| | Mechanisms of action on Escherichia coli of cecropin P1 and PR-39, two antibacterial peptides from pig intestine | Q40267880 |
| | Mouse cathelin-related antimicrobial peptide chemoattracts leukocytes using formyl peptide receptor-like 1/mouse formyl peptide receptor-like 2 as the receptor and acts as an immune adjuvant. | Q40425524 |
| | The antimicrobial peptide LL-37 activates innate immunity at the airway epithelial surface by transactivation of the epidermal growth factor receptor. | Q40609292 |
| | Formation of D-alanyl-lipoteichoic acid is required for adhesion and virulence of Listeria monocytogenes. | Q40750538 |
| | Relationship between Helicobacter pylori eradication and reduced duodenal and gastric ulcer recurrence: a review | Q40945807 |
| | The glycopeptide story--how to kill the deadly 'superbugs'. | Q41277106 |
| | Impact of self-assembly properties on antibacterial activity of short acyl-lysine oligomers | Q41390340 |
| | Mechanisms Mediating Bactericidal Properties and Conditions That Enhance the Potency of a Broad-Spectrum Oligo-Acyl-Lysyl | Q42041041 |
| | The life and death of Helicobacter pylori | Q42265608 |
| | Cell-wall interactions and the selective bacteriostatic activity of a miniature oligo-acyl-lysyl | Q42586537 |
| | Different anti-Candida activities of two human lactoferrin-derived peptides, Lfpep and kaliocin-1. | Q42589056 |
| | Detailed in vivo analysis of the role of Helicobacter pylori Fur in colonization and disease | Q42738155 |
| | Expanding the Helicobacter pylori genetic toolbox: modification of an endogenous plasmid for use as a transcriptional reporter and complementation vector | Q42909176 |
| | Design and characterization of a broad -spectrum bactericidal acyl-lysyl oligomer | Q43197654 |
| | Solution structure and refolding of the Mycobacterium tuberculosis pentapeptide repeat protein MfpA. | Q43225120 |
| | Inactivation of Helicobacter pylori cagA gene affects motility. | Q43463077 |
| | Analogous oligo-acyl-lysines with distinct antibacterial mechanisms. | Q43726823 |
| | Proteases in Escherichia coli and Staphylococcus aureus confer reduced susceptibility to lactoferricin B. | Q44160960 |
| | Tryptophan-rich antimicrobial peptides: comparative properties and membrane interactions | Q44221923 |
| | Attenuated virulence of Streptococcus agalactiae deficient in D-alanyl-lipoteichoic acid is due to an increased susceptibility to defensins and phagocytic cells | Q44570310 |
| | Staphylococcus aureus resists human defensins by production of staphylokinase, a novel bacterial evasion mechanism. | Q44714990 |
| | Amoxicillin for the treatment of Helicobacter pylori infection | Q44726556 |
| | The sodium-dependent D-glucose transport protein of Helicobacter pylori | Q46152195 |
| | Human beta-defensin-2 production in keratinocytes is regulated by interleukin-1, bacteria, and the state of differentiation | Q46167434 |
| | Empirical rescue therapy after Helicobacter pylori treatment failure: a 10-year single-centre study of 500 patients | Q46902198 |
| | Structure-activity relationship of human liver-expressed antimicrobial peptide 2. | Q50579724 |
| | Improved antimicrobial peptides based on acyl-lysine oligomers. | Q50995304 |
| | Chimeric streptogramin-tyrocidine antibiotics that overcome streptogramin resistance. | Q53867913 |
| | Identification of the initial binding sites of alphas2-casein f(183-207) and effect on bacterial membranes and cell morphology. | Q54419109 |
| | Lactoferricin B inhibits bacterial macromolecular synthesis in and | Q59239403 |
| | Comparison of the acid stability of azithromycin and erythromycin A | Q68448976 |
| | Response of Campylobacter pyloridis to antibiotics, bismuth and an acid-reducing agent in vitro--an ultrastructural study | Q69476408 |
| | Translocation of a channel-forming antimicrobial peptide, magainin 2, across lipid bilayers by forming a pore | Q71693926 |
| | Additive effect of clarithromycin combined with 14-hydroxy clarithromycin, erythromycin, amoxycillin, metronidazole or omeprazole against Helicobacter pylori | Q72190850 |
| | The cathelicidin anti-microbial peptide LL-37 is involved in re-epithelialization of human skin wounds and is lacking in chronic ulcer epithelium | Q73043045 |
| | The concentration-dependent membrane activity of cecropin A | Q73702003 |
| | Mechanism of action of the antimicrobial peptide buforin II: buforin II kills microorganisms by penetrating the cell membrane and inhibiting cellular functions | Q74352964 |
| | Absence of a post-antibiotic effect (PAE) of beta-lactams against Helicobacter pylori NCTC 11637 | Q77664840 |
| | Peptic ulcer disease | Q81486683 |
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Helicobacter pylori | Q180556 |
| | antimicrobial peptide | Q1201508 |
| | Helicobacter pylori infectious disease | Q4497153 |
| P1104 | number of pages | 13 | |
| P304 | page(s) | 378-390 | |
| P577 | publication date | 2011-11-07 | |
| P1433 | published in | Antimicrobial Agents and Chemotherapy | Q578004 |
| P1476 | title | The oligo-acyl lysyl antimicrobial peptide C₁₂K-2β₁₂ exhibits a dual mechanism of action and demonstrates strong in vivo efficacy against Helicobacter pylori | |
| P478 | volume | 56 | |